Prurisol (abacavir gylcolate) - Innovation Pharma
Cellceutix: Dermatology Overview (Cellceutix) - Jul 16, 2016 - "AUC values were comparable for both Prurisol and Ziagen, within 80% to 125% equivalence window, indicating equivalent systemic exposure. No serious adverse events, or other significant adverse events occurred over the course of the study" 
P1 data Psoriasis
http://cellceutix.com/wp-content/uploads/2014/06/Cellceutix_Corporate_Slide-Deck_DERMATOLOGY-Non-Confidential-July-2016-1-1.pdf
 
Jul 16, 2016
 
 
bd660cd2-fd76-4ce3-a19d-f28b9a287e85.jpg